Biochemistry 2003, 42:13449–13456.PubMedCrossRef 24. Filipek R, Potempa J, Bochtler M: A comparison of staphostatin B with standard mechanism serine protease inhibitors. J Biol Chem 2005, 280:14669–14674.PubMedCrossRef 25. Filipek buy CB-839 R, Rzychon M, Oleksy A, Gruca M, Dubin A, Potempa J, Bochtler M: The Staphostatin-staphopain complex: a forward binding inhibitor
in complex with its target cysteine protease. J Biol Chem 2003, 278:40959–40966.PubMedCrossRef 26. Filipek R, Szczepanowski R, Sabat A, Potempa J, Bochtler M: Prostaphopain B structure: a comparison of proregion-mediated and staphostatin-mediated protease inhibition. Biochemistry 2004, 43:14306–14315.PubMedCrossRef 27. Sund CJ, Rocha ER, Tzianabos AO, Wells WG, Gee JM, Reott MA, O’Rourke DP, Smith CJ: The Bacteroides fragilis transcriptome BVD-523 nmr response to oxygen and H2O2: the role of OxyR and its effect on survival and virulence. Mol Microbiol 2008, 67:129–142.PubMedCrossRef 28. Rocha ER, Smith CJ: Transcriptional regulation of the Bacteroides fragilis ferritin gene (ftnA) by redox stress. Microbiology 2004, 150:2125–2134.PubMedCrossRef PD-0332991 mw 29. Nakayama K: Rapid viability loss on exposure
to air in a superoxide dismutase-deficient mutant of Porphyromonas gingivalis. J Bacteriol 1994, 176:1939–1943.PubMed 30. Meuric V, Gracieux P, Tamanai-Shacoori Z, Perez-Chaparro J, Bonnaure-Mallet M: Expression patterns of genes induced by oxidative stress Afatinib ic50 in Porphyromonas gingivalis. Oral Microbiol Immunol 2008, 23:308–314.PubMedCrossRef 31. Ferreira EO, Falcao LS, Vallim DC, Santos FJ, Andrade JR, Andrade AF, Vommaro RC, Ferreira MC, Domingues RM: Bacteroides fragilis adherence to Caco-2 cells. Anaerobe 2002, 8:307–314.PubMedCrossRef 32. Seydel A, Gounon P, Pugsley AP:
Testing the ‘ + 2 rule’ for lipoprotein sorting in the Escherichia coli cell envelope with a new genetic selection. Mol Microbiol 1999, 34:810–821.PubMedCrossRef 33. Patrick S, McKenna JP, O’Hagan S, Dermott E: A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles. Microb Pathog 1996, 20:191–202.PubMedCrossRef 34. Grenier D, Mayrand D: Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect Immun 1987, 55:111–117.PubMed 35. Duncan L, Yoshioka M, Chandad F, Grenier D: Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004, 36:319–325.PubMedCrossRef 36. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H: Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380–3389.PubMedCrossRef 37. Swidsinski A, Loening-Baucke V, Herber A: Mucosal flora in Crohn’s disease and ulcerative colitis – an overview. J Physiol Pharmacol 2009,60(Suppl 6):61–71.PubMed 38.